scispace - formally typeset
E

Emilio Alvarez

Researcher at Hospital General Universitario Gregorio Marañón

Publications -  22
Citations -  1825

Emilio Alvarez is an academic researcher from Hospital General Universitario Gregorio Marañón. The author has contributed to research in topics: Standardized uptake value & Neoadjuvant therapy. The author has an hindex of 14, co-authored 22 publications receiving 1682 citations. Previous affiliations of Emilio Alvarez include Complutense University of Madrid & GlaxoSmithKline.

Papers
More filters
Journal ArticleDOI

Thousands of chemical starting points for antimalarial lead identification

TL;DR: Chemical structures and associated data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host–pathogen interaction related targets.
Journal ArticleDOI

18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation

TL;DR: Preliminary results observed suggest the potential utility of FDG-PET as a complementary diagnostic procedure in the initial clinical evaluation as well as in the assessment of chemoradiation response (any T downstaged event) of locally advanced rectal cancer.
Journal ArticleDOI

Screening and catalytic activity in organic synthesis of novel fungal and yeast lipases

TL;DR: Achremonium murorum, Monascus mucoroides, Arthroderma ciferri, Fusarium poae, Ovadendron sulphureo-ochraceum and Rhodotorula araucariae are described as lipase-producers for the first time and were tested as biocatalysts in several organic reactions using unnatural substrates.
Journal ArticleDOI

Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.

TL;DR: Females with an intense pathologic response to preoperative chemoradiotherapy have an excellent 3-year disease-free survival and this information might be of interest for stratification of patients in the development of adjuvant treatment trials.